Aytu biopharma appoints mark oki as chief financial officer

Englewood, co / accesswire / january 4, 2022 / aytu biopharma, inc. (nasdaq:aytu), a pharmaceutical company focused on commercializing novel therapeutics and consumer healthcare products, today announced that mark oki will join aytu as the company's chief financial officer effective january 17, 2022. mr. oki will serve as a member of aytu's executive committee and will report to josh disbrow, chief executive officer.
AYTU Ratings Summary
AYTU Quant Ranking